ArticleEClinicalMedicine2020

Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study.

Antonio Mastroianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.